Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Hair follicle stem cells and skin cells show promise for hair and skin therapies but need more research for clinical use.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Dogs could be good models for studying human hair growth and hair loss.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

High-potency steroids or tacrolimus are effective treatments for Erosive Pustular Dermatosis of the Scalp.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Linoleic acid from Malva verticillata seeds may help treat hair loss by promoting hair cell growth and blocking baldness signals.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.